IFNA1 Antikörper
Kurzübersicht für IFNA1 Antikörper (ABIN6939689)
Target
Alle IFNA1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Aufreinigung
- Purified by Protein A/G
-
Immunogen
- Purified recombinant human IFN-alpha1
-
Isotyp
- IgG1 kappa
-
-
-
-
Applikationshinweise
-
Positive Control: Stimulated human peripheral blood mononuclear cells.
Known Application: Flow Cytometry (0.5-1 μg/million cells), Western Blot (1-2 μg/mL), Immunohistochemistry (frozen), Immunofluorescence (0.5-1 μg/mL), Optimal dilution for a specific application should be determined.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 200 μg/mL
-
Buffer
- 10 mM PBS with 0.05 % BSA & 0.05 % azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-80 °C
-
Informationen zur Lagerung
- Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.
-
Haltbarkeit
- 24 months
-
-
- IFNA1 (Interferon, alpha 1 (IFNA1))
-
Andere Bezeichnung
- IFNA1
-
Hintergrund
- This MAb is specific for human interferon alpha 1 and does not cross react with human interferon alpha 2. Interferons are widely used therapeutic agents because of their anti-tumor and anti-viral effects and because of their modulatory effects on the immune system. These cytokines produce their effects by binding to the Type 1 Interferon- Receptor (IFNAR1). Down regulation of this receptor plays a key role in determining the magnitude and duration of cytokine signaling. This down regulation is influenced by phosphorylation of Serine 535 and 539 in the IFNAR1.
-
Molekulargewicht
- 16-27kDa
-
Gen-ID
- 3439
-
UniProt
- P01562
-
Pathways
- JAK-STAT Signalweg, Hepatitis C
Target
-